Zim Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Zim Laboratories Ltd · Outcome · 04 Nov 2026, 8:06 pm
Zim Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 10,545 (+18.9% YoY | +12.0% QoQ) ■ EBITDA: 543 (-5.7% YoY | +121.5% QoQ) ■ EBITDA Margin (%): 5.1 (-134 bps YoY | +255 bps QoQ) ■ PAT: -205 (-382.6% YoY | +49.0% QoQ) ■ EPS (INR): -0.38 (-322.2% YoY | +49.3% QoQ)
Original exchange filing (PDF)
More announcements from Zim Laboratories Ltd
- Transcript of Q2 & H1FY27 Earnings Conference Call · 12 Nov 2026
- Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call. · 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Earnings Presentation for Q2 & H1 FY27. · 05 Nov 2026
- Please find enclosed the financial results for the quarter and half year ended 30th September 2026 · 04 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, .... · 04 Nov 2026
- We wish to inform you that Q2 & H1FY27 Earnings Conference Call is scheduled to be held on Thursday, 05th November, 2026 at 11:00 a.m. IST. · 31 Oct 2026
- ZIM Laboratories Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 04 Nov 2026
- Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results .... · 04 Nov 2026
